Sale!

ARL6 Gene Bardet-Biedl Syndrome Type 3 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ARL6 Gene Bardet-Biedl Syndrome Type 3 Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, aimed at detecting mutations in the ARL6 gene, which are known to cause Bardet-Biedl Syndrome (BBS) Type 3. BBS is a rare genetic disorder characterized by symptoms such as vision loss, obesity, kidney dysfunction, and extra fingers or toes. The test is crucial for individuals with a family history of BBS or those showing symptoms, as it helps in confirming the diagnosis, understanding the risk of transmission to offspring, and facilitating personalized management and treatment plans. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test costs 4400 AED and provides a comprehensive genetic analysis with reliable results, contributing significantly to the medical care and genetic counseling of affected families.

Description

ARL6 Gene Bardet-Biedl syndrome type 3 Genetic Test

Test Name: ARL6 Gene Bardet-Biedl syndrome type 3 Genetic Test

Components: NGS Technology

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Test Type: Hepatology Nephrology Endocrinology Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for ARL6 Gene Bardet-Biedl syndrome type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ARL6 Gene Bardet-Biedl syndrome type 3 NGS Genetic DNA Test gene ARL6

Test Details:

The ARL6 gene is associated with Bardet-Biedl syndrome type 3 (BBS3), which is a rare genetic disorder characterized by a variety of symptoms including obesity, retinal degeneration, polydactyly (extra fingers or toes), intellectual disability, kidney abnormalities, and hormonal imbalances.

NGS (Next-Generation Sequencing) Genetic Test is a type of genetic testing that allows for the simultaneous analysis of multiple genes or even the entire genome. It uses advanced sequencing technologies to quickly and accurately identify variations in the DNA sequence, including mutations or changes in the ARL6 gene that may be responsible for Bardet-Biedl syndrome type 3.

The NGS Genetic Test for Bardet-Biedl syndrome type 3 would involve obtaining a DNA sample, typically through a blood sample or cheek swab, from the individual suspected of having the condition. The DNA is then sequenced using NGS technology, and the resulting data is analyzed to identify any variations or mutations in the ARL6 gene that may be causing the symptoms.

This type of genetic testing can provide valuable information for diagnosing Bardet-Biedl syndrome type 3, as well as for genetic counseling and family planning purposes. It can help determine the specific genetic cause of the condition, assess the risk of passing it on to future generations, and guide appropriate medical management and treatment options.

Test Name	ARL6 Gene Bardet-Biedl syndrome type 3 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Hepatology Nephrology Endocrinology Disorders
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for ARL6 Gene Bardet-Biedl syndrome type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ARL6 Gene Bardet-Biedl syndrome type 3 NGS Genetic DNA Test gene ARL6
Test Details	The ARL6 gene is associated with Bardet-Biedl syndrome type 3 (BBS3), which is a rare genetic disorder characterized by a variety of symptoms including obesity, retinal degeneration, polydactyly (extra fingers or toes), intellectual disability, kidney abnormalities, and hormonal imbalances. NGS (Next-Generation Sequencing) Genetic Test is a type of genetic testing that allows for the simultaneous analysis of multiple genes or even the entire genome. It uses advanced sequencing technologies to quickly and accurately identify variations in the DNA sequence, including mutations or changes in the ARL6 gene that may be responsible for Bardet-Biedl syndrome type 3. The NGS Genetic Test for Bardet-Biedl syndrome type 3 would involve obtaining a DNA sample, typically through a blood sample or cheek swab, from the individual suspected of having the condition. The DNA is then sequenced using NGS technology, and the resulting data is analyzed to identify any variations or mutations in the ARL6 gene that may be causing the symptoms. This type of genetic testing can provide valuable information for diagnosing Bardet-Biedl syndrome type 3, as well as for genetic counseling and family planning purposes. It can help determine the specific genetic cause of the condition, assess the risk of passing it on to future generations, and guide appropriate medical management and treatment options.